Trastuzumab Recruiting Phase 3 Trials for Stage I Breast Carcinoma / HER2 Positive Breast Cancers Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01785420Pre Operative Trastuzumab in Operable Breast Cancer